Association between polymorphisms in the β2-adrenoceptor gene and migraine in women

Headache

Volumn 49, Issue 2, 2009, Pages 235-244

  Schürks, Markus ^a   Kurth, Tobias ^a,b   Ridker, Paul M ^a,b   Buring, Julie E ^a,b,c   Zee, Robert Y L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Migraine; Woman; 2 adrenoceptor; 2 adrenoceptor gene

Indexed keywords

ADULT; ARTICLE; BETA2 ADRENOCEPTOR GENE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL; SELF REPORT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BETA 2 ADRENERGIC RECEPTOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 59449098462     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01207.x     Document Type: Article

References (45)

1. The International Classification of Headache Disorders: 2nd edn. Cephalalgia. 2004 24 (Suppl. 1 9 160.
2. Moskowitz MA. Pathophysiology of headache - past and present. Headache. 2007 47 (Suppl. 1 S58 S63.
3. Iadecola C. From CSD to headache: A long and winding road. Nat Med. 2002 8 : 110 112.
4. Humphrey PP. The discovery of a new drug class for the acute treatment of migraine. Headache. 2007 47 (Suppl. 1 S10 S19.
5. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol. 1995 52 : 129 134.
6. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: A prospective study. Neurology. 2005 64 : 1020 1026.
7. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: The Atherosclerosis Risk in Communities Study. Neurology. 2005 64 : 1573 1577.
8. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006 296 : 283 291.
9. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: The GEM population-based study. Neurology. 2005 64 : 614 620.
10. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med. 2007 167 : 795 801.
11. Aamodt AH, Stovner LJ, Langhammer A, Hagen K, Zwart JA. Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study. Headache. 2007 47 : 204 212.
12. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR. Association between migraine and asthma: Matched case-control study. Br J Gen Pract. 2002 52 : 723 727.
13. Johnson JA, Terra SG. Beta-adrenergic receptor polymorphisms: Cardiovascular disease associations and pharmacogenetics. Pharm Res. 2002 19 : 1779 1787.
14. Matheson MC, Ellis JA, Raven J, Johns DP, Walters EH, Abramson MJ. Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J Hum Genet. 2006 51 : 943 951.
15. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A HuGE review. Am J Epidemiol. 2005 162 : 201 211.
16. Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci. 2006 27 : 410 415.
17. Johannsson V, Nilsson LR, Widelius T, et al. Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache. 1987 27 : 372 374.
18. Liggett SB. Beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med. 2000 161 : S197 S201.
19. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 1993 8 : 334 339.
20. Chong LK, Chowdry J, Ghahramani P, Peachell PT. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics. 2000 10 : 153 162.
21. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol. 1995 13 : 25 33.
22. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994 33 : 9414 9419.
23. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000 9 : 19 27.
24. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005 352 : 1293 1304.
25. Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia. 2001 21 : 175 183.
26. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988 8 (Suppl. 7 1 96.
27. Zee RY, Hoh J, Cheng S, et al. Multi-locus interactions predict risk for post-PTCA restenosis: An approach to the genetic analysis of common complex disease. Pharmacogenomics J. 2002 2 : 197 201.
28. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995 29 : 311 322.
29. Lin DY, Zeng D. Likelihood-based inference on haplotype effects in genetic association studies. J Am Stat Assoc. 2006 101 : 89 104.
30. Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol. 2005 29 : 299 312.
31. Limmroth V, Michel MC. The prevention of migraine: A critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol. 2001 52 : 237 243.
32. Reznikoff GA, Manaker S, Rhodes CH, Winokur A, Rainbow TC. Localization and quantification of beta-adrenergic receptors in human brain. Neurology. 1986 36 : 1067 1073.
33. van Waarde A, Visser TJ, Elsinga PH, et al. Imaging beta-adrenoceptors in the human brain with (S)-1′-[18F]fluorocarazolol. J Nucl Med. 1997 38 : 934 939.
34. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006 59 : 652 661.
35. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine? Brain. 2005 128 : 86 97.
36. Zee RY, Cook NR, Reynolds R, Cheng S, Ridker PM. Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics. 2005 169 : 1583 1587.
37. Peroutka SJ. Migraine: A chronic sympathetic nervous system disorder. Headache. 2004 44 : 53 64.
38. Thijs RD, Kruit MC, van Buchem MA, Ferrari MD, Launer LJ, van Dijk JG. Syncope in migraine: The population-based CAMERA study. Neurology. 2006 66 : 1034 1037.
39. Guimaraes S, Moura D. Vascular adrenoceptors: An update. Pharmacol Rev. 2001 53 : 319 356.
40. Lamarre-Cliche M. Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope. Am J Cardiovasc Drugs. 2002 2 : 23 35.
41. Liggett SB, Wagoner LE, Craft LL, et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest. 1998 102 : 1534 1539.
42. D'Amato M, Vitiani LR, Petrelli G, et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med. 1998 158 : 1968 1973.
43. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology. 1999 53 : 537 542.
44. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
45. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005 18 : 305 310.